CEO of STELLANTIS Europe: We will never pay a fine for the EU emission reduction requirements in 2025, and we are ready to reduce production to avoid this situation.Market News: South Korean President Yin Xiyue may release a recorded public speech.The governor of the Swiss National Bank once again threatened negative interest rates, saying that it really worked. Martin Schlegel, governor of the Swiss National Bank, said that the bank did not like negative interest rates, but would use them again when necessary to curb speculation in the Swiss franc. Before his speech, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. The new central bank governor once again threatened to re-implement the negative interest rate policy if necessary. "Nobody likes negative interest rates, and neither does the Swiss National Bank," Schlegel told Bloomberg Television in Bern. "Of course, we will also be ready to implement negative interest rates again if necessary. But as we cut interest rates today, the possibility of negative interest rates has been reduced. "
Nanxin Technology: The equity of shareholders Shunwei Technology and its concerted actions changed to less than 5%. Nanxin Technology announced that the shareholders of the company Shunwei Technology and its concerted actions Hangzhou Shunying, Wuhan Shunying and Wuhan Shunhong reduced their holdings of the company's shares and passively diluted their equity, and the total number of shares held by the company changed from 30,843,800 shares to 21,272,800 shares, accounting for 7.2826% to 4.9999% of the company's total share capital, no longer.Yonghui Supermarket: There are no major matters that should be disclosed but not disclosed.French President Macron: Without Europeans, Europe will not be safe.
The International Finance Corporation (IFC) and HSBC signed a $1 billion trade flow arrangement for emerging markets.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.
Strategy guide
Strategy guide
12-14
Strategy guide
12-14